Cited by 550NF-κB Signaling PathwaysCell death mechanisms and regulationSignaling Pathways in Disease

RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis.

Open access
Ting, A. T., Pimentel‐Muiños, F. X., Seed, B.·1996·The EMBO Journal

Abstract

The CD95 (Fas/APO-1) and tumor necrosis factor (TNF) receptor pathways share many similarities, including a common reliance on proteins containing 'death domains' for elements of the membrane-proximal signal relay. We have created mutant cell lines that are unable to activate NF-kappaB in response to TNF. One of the mutant lines lacks RIP, a 74 kDa Ser/Thr kinase originally identified by its ability to associate with Fas/APO-1 and induce cell death. Reconstitution of the line with RIP restores responsiveness to TNF. The RIP-deficient cell line is susceptible to apoptosis initiated by anti-CD95 antibodies. An analysis of cells reconstituted with mutant forms of RIP reveals similarities between the action of RIP and FADD/MORT-1, a Fas-associated death domain protein.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1996.tb01007.x

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ting, A. T., Pimentel‐Muiños, F. X., & Seed, B.
Affiliations
Massachusetts General Hospital (US)
Venue
The EMBO Journal
Published
1996-11-01
Volume
15
Issue
22
Pages
6189-6196
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W135294775
Cited by
550
References
33
Citations by year
2026: 5 · 2025: 5 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 14 · 2017: 15 · 2016: 13 · 2015: 14 · 2014: 21 · 2013: 18 · 2012: 21
FWCI
11.50
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research Institute
  • Massachusetts General Hospital
  • National Institutes of Health (5r01dk043031-10)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 43031)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
receptor-interacting protein, RIP, tumor necrosis factor receptor 1, NF-κB activation, Fas/APO-1, Fas, apoptosis, death domain, TNF signaling, Ser/Thr kinase
MeSH terms
Animals, Cells, Cultured, DNA, Flow Cytometry, Gene Expression Regulation, Phosphatidylserines, Phosphoserine, Phosphothreonine, Proteins, Transfection, Immunoblotting, Blotting, Western, Mutagenesis, NF-kappa B, Apoptosis, Genes, Reporter, Receptors, Tumor Necrosis Factor, fas Receptor, Mice, Receptor-Interacting Protein Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review